ReviewMolecules (Basel, Switzerland)2018
Chemical and Biological Significance of Oenothein B and Related Ellagitannin Oligomers with Macrocyclic Structure.
Review in Molecules (Basel, Switzerland), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05306314 (A Study to Understand the Treatment Patterns in Patients With Chronic Bacterial Prostatitis), which is not on this map. Cited by 25 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
A Study to Understand the Treatment Patterns in Patients With Chronic Bacterial Prostatitis (Category II), Chronic Pelvic Pain (Category IIIA, IIIB)Treataprost Added to Standard Antibiotic Treatment in Real-life Clinical Practice
Who cites it
25 citing papers in PubMed, 58 citations in OpenAlex.
- Qualitative and quantitative standardisation ofPharmaceutical science advances · 2026Article
- Phytochemical Composition and Bioactivity ofMolecules (Basel, Switzerland) · 2026Review
- Article
- Unlocking the Therapeutic Potential of Ellagitannins: A Comprehensive Review of Key Representatives.Molecules (Basel, Switzerland) · 2025Review
- Ellagitannin Oligomers fromMolecules (Basel, Switzerland) · 2025Article
- The Involvement ofNutrients · 2025Review
- Phytochemical Insights and Therapeutic Potential ofMolecules (Basel, Switzerland) · 2025Review
- Exploring the Phytochemical Profile and Biological Insights ofPlants (Basel, Switzerland) · 2025Article
- The phenology ofFrontiers in pharmacology · 2025Article
- Antibacterial and Antimycotic Activity ofPharmaceuticals (Basel, Switzerland) · 2023Review
- Screening of Chemical Composition, Antimicrobial and Antioxidant Activities in Pomegranate, Quince, and Persimmon Leaf, Peel, and Seed: Valorization of Autumn Fruits By-Products for a One Health Perspective.Antibiotics (Basel, Switzerland) · 2023Article
- Chemical Characterization and Biological Evaluation ofPlants (Basel, Switzerland) · 2023Article
- Bioactive Compounds, Antioxidant Activity and Sensory Properties of Northern Red Oak (Molecules (Basel, Switzerland) · 2023Article
- The Impact of Solid-Phase Fermentation on Flavonoids, Phenolic Acids, Tannins and Antioxidant Activity inPlants (Basel, Switzerland) · 2023Article
- Article
- Review
- Oenothein B ameliorates hepatic injury in alcoholic liver disease mice by improving oxidative stress and inflammation and modulating the gut microbiota.Frontiers in nutrition · 2022Article
- Oenothein B in Eucalyptus Leaf Extract Suppresses Fructose Absorption in Caco-2 Cells.Molecules (Basel, Switzerland) · 2021Article
- Treatment of Benign Prostatic Hyperplasia by Natural Drugs.Molecules (Basel, Switzerland) · 2021Review
- Shedding Light into the Connection between Chemical Components and Biological Effects of Extracts fromAntioxidants (Basel, Switzerland) · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In 1990, Okuda et al. reported the first isolation and characterization of oenothein B, a unique ellagitannin dimer with a macrocyclic structure, from the
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.